about
Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions .Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone.Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of ClopidogrelClopidogrel Has No Clinically Meaningful Effect on the Pharmacokinetics of the Organic Anion Transporting Polypeptide 1B1 and Cytochrome P450 3A4 Substrate Simvastatin
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Matti K Itkonen
@ast
Matti K Itkonen
@en
Matti K Itkonen
@es
Matti K Itkonen
@nl
type
label
Matti K Itkonen
@ast
Matti K Itkonen
@en
Matti K Itkonen
@es
Matti K Itkonen
@nl
prefLabel
Matti K Itkonen
@ast
Matti K Itkonen
@en
Matti K Itkonen
@es
Matti K Itkonen
@nl
P106
P31
P496
0000-0003-1812-4397